Simply sign up to the Health sector myFT Digest -- delivered directly to your inbox. Rasmus Bech Hansen was consulting for life science companies when his mother developed cancer. He wanted to know ...

Estimated reduction in revenue for the US older adult market, based on updated ACIP recommendations in 2024 The US market for RSV vaccines for the elderly could have generated sales of $3.7bn in 2024 ...

London, England, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Today, Airfinity is launching the world’s first data and analytics platform dedicated to the breakthrough obesity treatments market. The platform ...

New analysis by Airfinity and Bloomberg News reveals outbreaks of diseases such as measles, whooping cough, tuberculosis and polio, as well as dengue and cholera are surging worldwide. London, England ...

BEIJING (Reuters) -Around 9,000 people in China are probably dying each day from COVID-19, UK-based health data firm Airfinity said on Thursday, nearly doubling its estimate from a week ago, as ...

Dwindling demand for Covid antivirals is poised to offset strong sales from the first half of 2022, according to health analytics firm Airfinity, as officials in the U.S. and around the world urge ...

Climate change, growth in international travel, increasing populations and the threat posed by zoonotic diseases contribute to the risk, according to London-based Airfinity Ltd. But if effective ...

London, England, July 24, 2024 (GLOBE NEWSWIRE) -- Airfinity has reduced its sales projections for vaccines against Respiratory Syncytial Virus (RSV) for older adults in the US from $4.7bn per year to ...

The MarketWatch News Department was not involved in the creation of this content. Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for ...

Estimated reduction in revenue for the US older adult market, based on updated ACIP recommendations in 2024 Estimated revenue for the US older adult market in 2030, based on different booster ...